Why it was recalled
Failed Impurities/Degradation Specifications
Product description
allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.
Lot numbers, UPCs & expiration codes
Lot #: a) 2HE2032, 2JE1882, 2JE2185 Exp. Date 01/24; b) 2DR0464, 2ER0410, Exp. Date 12/23; 2ER0286, 2ER0411, Exp. Date 01/24 c) 2DR0467, 2DR0468, 2DR0469, 2ER0288, Exp. Date 12/23 d) 2ER0414, Exp. Date 01/24, 2GR0333, Exp. Date 02/24
Where it was sold
Nationwide within the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0910-2023
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Feb 9, 2023
- FDA report date
- Jul 19, 2023
- Quantity
- 208,416 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- L. Perrigo Company
Original FDA data
Every field from FDA enforcement report D-0910-2023, exactly as published.
Show all FDA fields
- City
- Allegan
- State
- MI
- Status
- Terminated
- Country
- United States
- Event ID
- 91672
- Address
- 515 Eastern Ave
- Code information
- Lot #: a) 2HE2032, 2JE1882, 2JE2185 Exp. Date 01/24; b) 2DR0464, 2ER0410, Exp. Date 12/23; 2ER0286, 2ER0411, Exp. Date 01/24 c) 2DR0467, 2DR0468, 2DR0469, 2ER0288, Exp. Date 12/23 d) 2ER0414, Exp. Date 01/24, 2GR0333, Exp. Date 02/24
- Postal code
- 49010-9070
- Report date
- Jul 19, 2023
- Product type
- Drugs
- Recall number
- D-0910-2023
- Classification
- Class II
- Recalling firm
- L. Perrigo Company
- Product quantity
- 208,416 cartons
- Termination date
- Sep 11, 2023
- Reason for recall
- Failed Impurities/Degradation Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.
- Distribution pattern
- Nationwide within the USA
- Recall initiation date
- Feb 9, 2023
- Initial firm notification
- Letter
- Center classification date
- Jul 11, 2023